The Hull Family Cardiac Fibrillation Management Laboratory, Division of Cardiology, Toronto General Hospital, Toronto, Ontario, Canada.
J Cardiovasc Electrophysiol. 2013 Jul;24(7):813-21. doi: 10.1111/jce.12162. Epub 2013 May 3.
Transplantation of mesenchymal stem cells (MSCs) has shown therapeutic potential for cardiovascular diseases, but the electrophysiological implications are not understood. The purpose of this study was to evaluate the impact of MSC transplantation on adverse electrophysiological remodeling in the heart following myocardial infarction (MI).
Three weeks after coronary ligation to induce MI in rats, MSCs or culture medium were directly injected into each infarct. One to two weeks later, hearts were excised, Langendorff-perfused, and optically mapped using the potentiometric fluorescent dye Di-4-ANEPPS. Quantitative real-time PCR was also performed to assess gene expression. Optical mapping showed that post-MI reduction in conduction velocity (from 0.70 ± 0.04 m/s in 12 normal controls to 0.47 ± 0.02 m/s in 11 infarcted hearts, P < 0.05) was attenuated with MSC transplantation (0.65 ± 0.04 m/s, n = 18, P < 0.05). Electrophysiological changes correlated with higher vascular density and better-preserved ventricular geometry in MSC-transplanted hearts. A number of ion channel genes showed changes in RNA expression following infarction. In particular, the expression of Kir2.1, which mediates the inward rectifier potassium current, I(K1), was reduced in infarcted tissues (n = 7) to 13.8 ± 3.7% of normal controls, and this post-MI reduction was attenuated with MSC transplantation (44.4 ± 11.2%, n = 7, P < 0.05).
In addition to promoting angiogenesis and limiting adverse structural remodeling in infarcted hearts, MSC transplantation also alters ion channel expression and mitigates electrophysiological remodeling. Further understanding of the electrophysiological impact of MSC transplantation to the heart may lead to the development of cell-based therapies for post-MI arrhythmias.
间充质干细胞(MSCs)移植对心血管疾病具有治疗潜力,但对其电生理影响尚不清楚。本研究旨在评估 MSC 移植对心肌梗死后心脏不良电生理重构的影响。
在大鼠冠状动脉结扎诱导心肌梗死后 3 周,将 MSC 或培养基直接注射到每个梗死部位。1 至 2 周后,取出心脏,Langendorff 灌流,并使用电势荧光染料 Di-4-ANEPPS 进行光学标测。还进行了定量实时 PCR 以评估基因表达。光学标测显示,心肌梗死后,传导速度(从 12 个正常对照组的 0.70 ± 0.04 m/s 降低到 11 个梗死组的 0.47 ± 0.02 m/s,P < 0.05)被 MSC 移植减弱(0.65 ± 0.04 m/s,n = 18,P < 0.05)。电生理变化与 MSC 移植心脏中更高的血管密度和更好保存的心室几何形状相关。许多离子通道基因在梗死后的 RNA 表达发生变化。特别是,介导内向整流钾电流 I(K1)的 Kir2.1 基因在梗死组织中的表达(n = 7)降低到正常对照组的 13.8 ± 3.7%,而 MSC 移植后这种梗死后的降低被减弱(44.4 ± 11.2%,n = 7,P < 0.05)。
除了促进梗死心脏的血管生成和限制不良结构重构外,MSC 移植还改变离子通道表达并减轻电生理重构。进一步了解 MSC 移植对心脏的电生理影响可能导致开发用于心肌梗死后心律失常的基于细胞的治疗方法。